Effects of Chronic Intake of Cannabis on Contrast Sensitivity
Primary Purpose
Cannabis Dependence
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
electroretinogram
contrast sensitivity tests
Sponsored by
About this trial
This is an interventional other trial for Cannabis Dependence
Eligibility Criteria
Inclusion Criteria:
"Cannabis" Arm
- patient addicted to cannabis
- Positive CAST test result
- Urine tested positive for cannabis metabolites
"Tobacco" Arm
- positive Fagerström test result
- No cannabis intake in the last year before inclusion
- No previous history of cannabis use
"Healthy Volunteers"
- No tobacco or cannabis intake in the last year before inclusion
- No history of addictive disorders
Exclusion Criteria:
- addiction to other substances than cannabis or tobacco
- benzodiazepine treatment
- patient with history of benzodiazepine treatment
- patient with history of general anesthesia in the last 3 months before inclusion
- patient with history of head trauma
- Pregnant woman
- breast feeding woman
- Adults under supervision or guardianship
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Other
Other
Other
Arm Label
"Cannabis" Arm
"Tobacco" Arm
"Healthy volunteers"
Arm Description
patient addicted to cannabis
patient addicted to tobacco
no smokers
Outcomes
Primary Outcome Measures
The contrast detection treshold
Comparison of the contrast detection threshold of the 3 groups
Secondary Outcome Measures
Full Information
NCT ID
NCT01793961
First Posted
February 12, 2013
Last Updated
July 10, 2019
Sponsor
University Hospital, Strasbourg, France
1. Study Identification
Unique Protocol Identification Number
NCT01793961
Brief Title
Effects of Chronic Intake of Cannabis on Contrast Sensitivity
Official Title
Effects of Chronic Intake of Cannabis on Contrast Sensitivity
Study Type
Interventional
2. Study Status
Record Verification Date
July 2019
Overall Recruitment Status
Completed
Study Start Date
March 22, 2013 (Actual)
Primary Completion Date
November 30, 2015 (Actual)
Study Completion Date
September 10, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University Hospital, Strasbourg, France
4. Oversight
5. Study Description
Brief Summary
Rates of driving under the influence of cannabis have risen in recent years. Cannabis is involved in 1/3 of motor vehicle collisions. The chronic use of cannabis is known to affect dopaminergic regulation and may thus impair contrast sensitivity. In turn, contrast sensitivity disorders could originate difficulties to anticipate and avoid collision with objects, especially when objects are in movement. The investigators goal is to examine the effects of a chronic intake of cannabis on contrast sensitivity. The observed values will be compared to standard references. In addition, since smoking cannabis is always associated with tobacco, the investigators will control the effects of tobacco on contrast sensitivity.
In this study, the investigators will include 36 cannabis addicts, 36 tobacco addicts and 36 no smokers. The investigators will present gratings with different spatial frequencies and the investigators will determine contrast thresholds for static and dynamic (moving) gratings. The investigators predict that cannabis addicts will present abnormal contrast sensitivity especially in case of dynamic presentation of gradings.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cannabis Dependence
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
95 (Actual)
8. Arms, Groups, and Interventions
Arm Title
"Cannabis" Arm
Arm Type
Other
Arm Description
patient addicted to cannabis
Arm Title
"Tobacco" Arm
Arm Type
Other
Arm Description
patient addicted to tobacco
Arm Title
"Healthy volunteers"
Arm Type
Other
Arm Description
no smokers
Intervention Type
Other
Intervention Name(s)
electroretinogram
Intervention Type
Other
Intervention Name(s)
contrast sensitivity tests
Primary Outcome Measure Information:
Title
The contrast detection treshold
Description
Comparison of the contrast detection threshold of the 3 groups
Time Frame
up to 9 days after inclusion
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
50 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
"Cannabis" Arm
patient addicted to cannabis
Positive CAST test result
Urine tested positive for cannabis metabolites
"Tobacco" Arm
positive Fagerström test result
No cannabis intake in the last year before inclusion
No previous history of cannabis use
"Healthy Volunteers"
No tobacco or cannabis intake in the last year before inclusion
No history of addictive disorders
Exclusion Criteria:
addiction to other substances than cannabis or tobacco
benzodiazepine treatment
patient with history of benzodiazepine treatment
patient with history of general anesthesia in the last 3 months before inclusion
patient with history of head trauma
Pregnant woman
breast feeding woman
Adults under supervision or guardianship
12. IPD Sharing Statement
Learn more about this trial
Effects of Chronic Intake of Cannabis on Contrast Sensitivity
We'll reach out to this number within 24 hrs